Biological heterogeneity in localized high-risk prostate cancer (LHRPC) from a study of neoadjuvant abiraterone acetate plus leuprolide acetate (LHRHa) versus LHRHa. This is an ASCO Meeting Abstract ...
Sexual health outcomes in sexual minority vs. heterosexual men after prostate radiotherapy. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not include a full ...